4.7 Article

Thrombomodulin facilitates peripheral nerve regeneration through regulating M1/M2 switching

Journal

JOURNAL OF NEUROINFLAMMATION
Volume 17, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12974-020-01897-z

Keywords

Thrombomodulin; Macrophage polarization; Peripheral nerve regeneration; Inflammation; IL-4 receptor; STAT6

Funding

  1. Ministry of Science and Technology [MOST 105-2314-B-006-041-MY5, MOST 104-2320-B-006-003, MOST 105-2320-B-006-003, MOST 106-2320-B-006-003, MOST 107-3017-F-006-002]
  2. National Health Research Institutes of Taiwan [NHRI-EX106-10525EI, NHRI-EX109-10925EI]
  3. International Center for Wound Repair and Regeneration at National Cheng Kung University from The Featured Areas Research Center Program

Ask authors/readers for more resources

Background Excessive inflammation within damaged tissue usually leads to delayed or insufficient regeneration, and nerves in the peripheral nervous system (PNS) generally do not recover fully following damage. Consequently, there is growing interest in whether modulation of the inflammatory response could help to promote nerve regeneration in the PNS. However, to date, there are no practical therapeutic strategies for manipulating inflammation after nerve injury. Thrombomodulin (TM) is a transmembrane glycoprotein containing five domains. The lectin-like domain of TM has the ability to suppress the inflammatory response. However, whether TM can modulate inflammation in the PNS during nerve regeneration has yet to be elucidated. Methods We investigated the role of TM in switching proinflammatory type 1 macrophages (M1) to anti-inflammatory type 2 macrophages (M2) in a human monocytic cell line (THP-1) and evaluated the therapeutic application of TM in transected sciatic nerve injury in rats. Results The administration of TM during M1 induction significantly reduced the expression levels of inflammatory cytokines, includingTNF-a(p< 0.05),IL-6(p< 0.05), andCD86(p< 0.05), in THP-1 cells. Simultaneously, the expression levels of M2 markers, includingIL-10(p< 0.05) andCD206(p< 0.05), were significantly increased in TM-treated THP-1 cells. Inhibition of IL-4R-c-Myc-pSTAT6-PPAR gamma signaling abolished the expression levels ofIL-10(p< 0.05) andCD206(p< 0.05). The conditioned medium (CM) collected from M1 cells triggered an inflammatory response in primary Schwann cells, while CM collected from M1 cells treated with TM resulted in a dose-dependent reduction in inflammation. TM treatment led to better nerve regeneration when tested 6 weeks after injury and preserved effector muscle function. In addition, TM treatment reduced macrophage infiltration at the site of injury and led to potent M1 to M2 transition, thus indicating the anti-inflammatory capacity of TM. Conclusions Collectively, our findings demonstrate the anti-inflammatory role of TM during nerve regeneration. Therefore, TM represents a potential drug for the promotion and modulation of functional recovery in peripheral nerves that acts by regulating the M1/M2 ratio.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available